48,830
edits
Line 48: | Line 48: | ||
===WHO classification of 2017=== | ===WHO classification of 2017=== | ||
Five categorizes:<!-- https://www.esp-congress.org/fileadmin/user_upload/Congress_2016/IAP_ESP_Presentations/Mon/0830-1200/SY-02/SY-02-004-Kl%C3%B6ppel-Update%20of%20WHO%20classification%20of%20endocrine%20pancreatic%20tumours.pdf --> | Five categorizes:<!-- https://www.esp-congress.org/fileadmin/user_upload/Congress_2016/IAP_ESP_Presentations/Mon/0830-1200/SY-02/SY-02-004-Kl%C3%B6ppel-Update%20of%20WHO%20classification%20of%20endocrine%20pancreatic%20tumours.pdf --> | ||
* | *NET G1. | ||
* | *NET G2. | ||
* | *NET G3. | ||
*Neuroendocrine carcinoma. | *Neuroendocrine carcinoma. | ||
*[[MiNEN]]. | *[[MiNEN]]. |
edits